Zenas BioPharma raises $225 mln in US IPO-March 2024-www.financetom.com

Zenas BioPharma raises $225 mln in US IPO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Zenas BioPharma raises $225 mln in US IPO

Sep 13, 2024 2:07 PM

Sept 12 (Reuters) - Zenas BioPharma, which is developing

immunology-based therapies, said on Thursday it has raised $225

million in its U.S. initial public offering.

The clinical-stage company, backed by drugmaker

Bristol-Myers Squibb ( BMY ), priced its offering of 13.2

million shares at $17 each, midpoint of its targeted range of

$16 to $18 per share.

Previous page： Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study Next page： BRIEF-Mister Car Wash To Be Taken Private By Leonard Green & Partners For $7.00 Per Share

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study

Mar 11, 2026

Feb 18 (Reuters) - Eli Lilly ( LLY ) said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed better results in patients with the skin disease and obesity in a late-stage study, ‌compared to Taltz alone. The drugs showed greater improvement in skin ⁠symptoms and weight loss in the study that had ⁠274 patients. About 27.1%...

BRIEF-Mister Car Wash To Be Taken Private By Leonard Green & Partners For $7.00 Per Share

Mar 11, 2026

Feb 18 (Reuters) - Mister Car Wash Inc ( MCW ): * MISTER CAR WASH ‌TO BE ⁠TAKEN PRIVATE BY ⁠LEONARD GREEN & PARTNERS FOR $7.00 ‌PER ‌SHARE * MISTER CAR WASH ( MCW ) INC - ‌DEAL IMPLIES TOTAL ENTERPRISE VALUE OF $3.1 BILLION * MISTER ‌CAR WASH INC - UPON COMPLETION, CO ⁠TO BECOME PRIVATELY HELD, ⁠DELISTED FROM...

Merck to Collaborate With Mayo Clinic on AI-Enabled Drug Discovery

Mar 11, 2026

07:30 AM EST, 02/18/2026 (MT Newswires) -- Merck & Co. ( MRK ) said Wednesday it has signed a research and development agreement with Mayo Clinic to apply artificial intelligence and advanced analytics to support drug discovery. The collaboration will combine Mayo Clinic's clinical and genomic datasets with Merck's ( MRK ) research programs, the companies said. The Mayo Clinic...

Sharon AI Announces Nasdaq Listing and Pricing of $125 Million U.S. Initial Public Offering

Mar 11, 2026

NEW YORK--(BUSINESS WIRE)-- SharonAI Holdings Inc. ( SHAZ ) and its subsidiaries (“Sharon AI” or the “Company”), a leading Australian Neocloud, today announced the pricing of its initial public offering (the “Offering”) in the United States of 4,166,666 shares of its Class A Ordinary Common Stock (the “Common Stock”) at a public offering price of $30.00 per share, for total...